METRO EAST DRUGTREATMENT CORPORATION
NPI 1023229077
Community/Behavioral Health in Detroit, MI

Q: What is Metro East Drugtreatment Corporation's NPI number?

The NPI number for Metro East Drugtreatment Corporation is 1023229077. It was assigned to this organization in the NPPES registry on May 24, 2007. The provider is doing business as Metro East Drug Treatment Corporation. The provider is also known as Metro East Drug Treatment Coporation.

Q: What is Metro East Drugtreatment Corporation's specialty?

The primary specialty registered for this NPI is Community/Behavioral Health with taxonomy code 251S00000X.

Active since May 24, 2007CLIA 23D2158002 · Waiver

13929 HARPER AVE, DETROIT, MI 48213(313) 371-0055(313) 371-1409 Get Directions Write a Review

NPPES record last updated: April 1, 2025. Verified against the NPPES registry weekly; last sync: July 26, 2026.

Record update history: Apr 1, 2025, May 13, 2020 (2 updates tracked since 2020).

On this page

About Metro East Drugtreatment Corporation NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

METRO EAST DRUGTREATMENT CORPORATION (NPI 1023229077), doing business as Metro East Drug Treatment Corporation, is a healthcare organization registered as a community/behavioral health in Detroit, Michigan and active in the NPI registry since May 2007. The organization holds a CLIA Waiver certificate valid through November 18, 2026 and lists Daborah Carroll, Program Sponsor, as its authorized official.

NPPES Registry Identity

NPI1023229077

Entity TypeOrganization

Primary Taxonomy251S00000X

Legal Business NameMETRO EAST DRUGTREATMENT CORPORATION

Location Address13929 HARPER AVEDetroit, MI 48213-3672

Mailing Address13929 Harper AveDetroit, MI 48213-3672 · (313) 371-0055 · Fax (313) 371-1409

Phone(313) 371-0055

Fax(313) 371-1409

Organization SubpartNo

Authorized OfficialDaborah CarrollProgram Sponsor · (313) 371-0055

Enumeration DateMay 24, 2007

Last NPPES UpdateApril 1, 20252 updates tracked since enumeration

NPPES CertifiedApril 1, 2025

✔ NPI 1023229077 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

★ Primary SpecialtyCommunity/Behavioral HealthAgencies

Taxonomy Code251S00000X

License✔ Licensed in MI · 821237

Definition

A private or public agency usually under local government jurisdiction, responsible for assuring the delivery of community based mental health, intellectual disabilities, substance abuse and/or behavioral health services to individuals with those disabilities. Services may range from companion care, respite, transportation, community integration, crisis intervention and stabilization, supported employment, day support, prevocational services, residential support, therapeutic and supportive consultation, environmental modifications, intensive in-home therapy and day treatment, in addition to traditional mental health and behavioral treatment.

13929 HARPER AVE, Detroit, MI 48213

Open in Google Maps ↗

Other Names 2

Doing Business AsMetro East Drug Treatment Corporation

Other NameMetro East Drug Treatment Coporation

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 23D2158002

Metro East Drug Treatment Corporation · Detroit, MI

Active · expires Nov 18, 2026

CLIA Number23D2158002

Laboratory TypeMat/Otp

Certificate Effective DateNovember 19, 2024

Certificate Expiration DateNovember 18, 2026

Laboratory DirectorDaborah Carroll

Laboratory Phone(888) 810-0848

Laboratory LocationMetro East Drug Treatment Corporation13929 Harper Avenue, Detroit, MI 48213

CLIA data matches this NPI record on: Address Name

This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 4

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm G2067

Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.

1,040 services33 patients

Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure G2078

This service provides an additional 7-day supply of methadone, a medication used to treat opioid addiction, for patients to take at home. It's provided by a Medicare-enrolled opioid treatment program. This service is billed separately from the main treatment procedure.

779 services33 patients

Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for G2077

Periodic assessment is a routine check-up by trained professionals to determine the best mix of services and treatments for your health needs. This is typically provided by a Medicare-enrolled opioid treatment program. It's listed separately in addition to your main treatment code. This ensures you receive the most suitable care for your situation.

109 services32 patients

Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) G2074

Medication Assisted Treatment is a comprehensive program for managing substance use. It includes counseling (both individual and group), along with regular toxicology testing if required. This service is provided by a Medicare-enrolled opioid treatment program.

55 services20 patients

Leave this field empty

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

CONCEPTION COYNE

Counselor (Addiction (Substance Use Disorder))